Nutex Health Faces Legal Challenge Over Alleged Financial Misconduct

Nutex Health Faces Legal Challenge Over Alleged Financial Misconduct

2025-10-14 companies

San Francisco, Monday, 13 October 2025.
Nutex Health is embroiled in a lawsuit alleging it inflated revenue figures, misleading investors and impacting stock performance. The lawsuit, driven by Hagens Berman, seeks to address these claims.

Allegations of Revenue Inflation

Nutex Health Inc. (NASDAQ: NUTX), a prominent operator of micro-hospitals, is currently facing a class-action lawsuit that accuses the company of engaging in a scheme to inflate its revenue figures. Filed by the law firm Hagens Berman, the lawsuit claims that Nutex, in collaboration with the third-party billing firm HaloMD, submitted ineligible insurance claims. This allegedly deceptive billing strategy was intended to artificially boost the company’s financial results, thereby misleading investors and causing significant financial losses when the truth emerged [1][2].

Details and Implications of the Lawsuit

The lawsuit, filed on October 12, 2025, in a Texas federal court, alleges that Nutex exploited the insurance arbitration process by submitting thousands of questionable claims. These claims were reportedly falsified to extract outsized reimbursements, leading to unsustainable revenue figures and misstated financial performance. The period covered by the lawsuit, referred to as the ‘Class Period,’ spans from August 8, 2024, to August 14, 2025 [1][2][3].

Impact on Investor Confidence

The allegations have had a profound impact on investor confidence. Following the publication of a report by activist short-seller Blue Orca Capital on July 22, 2025, which accused Nutex of engaging in a ‘fraudulent scheme,’ the company’s stock fell by 10.05% to $100.01 per share. Further declines were observed on August 15, 2025, when the stock price dropped by 16.39% to $92.91 per share, reflecting investor concerns over the company’s financial integrity [4][5].

Investors affected by the alleged misconduct have until October 21, 2025, to request appointment as lead plaintiff in the ongoing class-action lawsuit. This deadline is critical for those seeking to recover losses incurred during the Class Period. The outcome of these legal proceedings could have far-reaching implications for Nutex Health’s future operations and investor relations [1][6][7].

Sources


lawsuit Nutex Health